US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Direxion Daily S&P Biotech Bull 3x Shares

296.31

+0.55000.19%

Pre-market: 288.50-7.8100-2.64%08:56 EDT

Volume:260.53K

Turnover:75.10M

Market Cap:570.24M

PE:- -

High:300.34

Open:290.97

Low:281.50

Close:295.76

52wk High:341.93

52wk Low:71.88

Shares:1.92M

Float Shares:1.92M

Volume Ratio:0.69

T/O Rate:13.54%

Dividend:1.01

Dividend Rate:0.34%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

CSPC Innovation Pharma's Colorectal Cancer Drug Gets US FDA's Fast Track Designation; Shares Up 4%

MT Newswires Live

IHH Healthcare's 2QFY2026 patmi up 29% y-o-y

The Edge Singapore

Nicox Gets 2027 FDA Decision Date for Glaucoma Drug NCX 470

Zymeworks (ZYME) Secures FDA Approval And $250 Million Milestone, Is The Stock Still Undervalued?

Simply Wall St.

Promisia shareholders back acquisition and board fee increase at 2026 AGM

Alkane Resources Stock Tops Financially Strong Penny Stocks To Watch

Simply Wall St.

Ramsay Health Care (RMSYF) Receives a Hold from Citi

Sigma Healthcare-Chemist Warehouse Merger Delivers Strong First Full-Year Results

Ramsay Health Care Declares Interim Dividend of AUD 0.485 per Share

Health Care Down on Rotation Out of Biotech

Vital Healthcare Property Trust Opens Director Nominations Ahead of November AGM

Health Care Roundup: Market Talk

Revolution Medicines Earns Buy as RASONQUE FDA Approval and Strong Pricing Outlook Drive Price Target Increase to $315

FDA Grants Landmark Approval to Revolutionary Medicines' Pancreatic Cancer Therapy, Projected to Exceed $9 Billion in Sales by 2032

FDA Approves Test to Identify Gastroesophageal Cancer Patients Eligible for Jazz Pharmaceuticals' Ziihera

MT Newswires Live

3 AI Healthcare Stocks Retail Investors Are Watching In Australia

Simply Wall St.

Sector Update: Healthcare

MT Newswires Live

Roche receives FDA approval for companion diagnostic tests for Ziihera

Analysts’ Top Healthcare Picks: CVS Health (CVS), TuHURA Biosciences (HURA)

Botanix Pharm: Strong Sofdra Adoption and Margin Upside Support Buy Rating with Unchanged $1 Price Target

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://au1.tigerplaytime.com/stock/LABU/news?page=8"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"LABU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LABU\",,,,,undefined,":{"symbol":"LABU","market":"US","secType":"STK","nameCN":"Direxion Daily S&P Biotech Bull 3x Shares","latestPrice":296.31,"timestamp":1788206400000,"preClose":295.76,"halted":0,"volume":260525,"hourTrading":{"tag":"盘前","latestPrice":288.5,"preClose":296.31,"latestTime":"08:56 EDT","volume":3711,"amount":1072156.81098,"timestamp":1788267372126,"change":-7.81,"changeRate":-0.026358,"amplitude":0.034741},"delay":0,"changeRate":0.0018596159047877042,"floatShares":1924486,"shares":1924486,"eps":0,"marketStatus":"Pre-Mkt","change":0.55,"latestTime":"09-01 08:59:34 EDT","open":290.97,"high":300.34,"low":281.5,"amount":75101085.83125001,"amplitude":0.0637,"askPrice":291.6,"askSize":200,"bidPrice":287.2,"bidSize":200,"shortable":3,"etf":3,"ttmEps":0,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1788269400000},"marketStatusCode":1,"adr":0,"adrRate":0,"exchange":"ARCA","adjPreClose":296.31,"sharesOutstanding":3074486,"nav":295.545,"aum":568772231.45,"dividendRate":0.0034,"bidAskSpread":0.002847,"preHourTrading":{"tag":"盘前","latestPrice":288.5,"preClose":296.31,"latestTime":"08:56 EDT","volume":3711,"amount":1072156.81098,"timestamp":1788267372126,"change":-7.81,"changeRate":-0.026358,"amplitude":0.034741},"postHourTrading":{"tag":"盘后","latestPrice":295.02,"preClose":296.31,"latestTime":"19:59 EDT","volume":2518,"amount":745089.4272,"timestamp":1788220773434,"change":-1.29,"changeRate":-0.004354,"amplitude":0.010268},"volumeRatio":0.6867414366828442,"impliedVol":0.9253,"impliedVolPercentile":0.5777},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LABU\",,,,,undefined,":{"symbol":"LABU","floatShares":1924486,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.6867414366828442,"shares":1924486,"dividePrice":1.0075,"high":300.34,"amplitude":0.0637,"preClose":295.76,"low":281.5,"week52Low":71.88,"pbRate":"--","week52High":341.93,"institutionHeld":0,"latestPrice":296.31,"eps":0,"divideRate":0.0034,"volume":260525,"delay":0,"ttmEps":0,"open":290.97,"prevYearClose":159.39,"prevWeekClose":295.76,"prevMonthClose":296.31,"prevQuarterClose":292.1,"fiveDayClose":308.33,"twentyDayClose":228.04,"sixtyDayClose":179.22},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/LABU\",params:#limit:5,,,undefined,":[{"date":"2025-09-23","symbol":"LABU","amount":0.10273,"announcedDate":"2025-09-22","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-09-23","defaultRemindTime":1758634200000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-30","payableDate":"2025-09-23","currency":"USD","dateTimestamp":1758600000000,"payDate":"2025-09-30"},{"date":"2025-06-24","symbol":"LABU","amount":0.21897,"announcedDate":"2025-06-23","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-06-24","defaultRemindTime":1750771800000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-07-01","payableDate":"2025-06-24","currency":"USD","dateTimestamp":1750737600000,"payDate":"2025-07-01"},{"date":"2025-03-25","symbol":"LABU","amount":0.10714,"announcedDate":"2025-03-24","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-03-25","defaultRemindTime":1742909400000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-04-01","payableDate":"2025-03-25","currency":"USD","dateTimestamp":1742875200000,"payDate":"2025-04-01"},{"date":"2024-06-25","symbol":"LABU","amount":0.15021,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-06-25","defaultRemindTime":1719322200000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-07-02","payableDate":"2024-06-25","currency":"USD","dateTimestamp":1719288000000,"payDate":"2024-07-02"},{"date":"2024-03-19","symbol":"LABU","amount":0.16064,"announcedDate":"2024-03-18","type":"dividend","market":"US","newRecordDate":"2024-03-20","defaultRemindTime":1710855000000,"name":"三倍做多标普生物-Direxion","recordDate":"2024-03-26","payableDate":"2024-03-20","currency":"USD","dateTimestamp":1710820800000,"payDate":"2024-03-26"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"LABU\",market:\"US\",,,undefined,":[{"executeDate":"2018-06-19","recordDate":"2018-06-20","paymentDate":"2018-06-26","value":0.01932,"currency":"USD"},{"executeDate":"2018-09-25","recordDate":"2018-09-26","paymentDate":"2018-10-02","value":0.0954,"currency":"USD"},{"executeDate":"2018-12-27","recordDate":"2018-12-28","paymentDate":"2019-01-04","value":0.09621,"currency":"USD"},{"executeDate":"2019-03-19","recordDate":"2019-03-20","paymentDate":"2019-03-26","value":0.10973,"currency":"USD"},{"executeDate":"2019-06-25","recordDate":"2019-06-26","paymentDate":"2019-07-02","value":0.03745,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"LABU\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"LABU\",pageSize:20,pageCount:8,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2662483775","title":"CSPC Innovation Pharma's Colorectal Cancer Drug Gets US FDA's Fast Track Designation; Shares Up 4%","url":"https://stock-news.laohu8.com/highlight/detail?id=2662483775","media":"MT Newswires Live","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662483775?lang=en_us&edition=fundamental","pubTime":"2026-08-27 14:51","pubTimestamp":1787813504,"startTime":"0","endTime":"0","summary":"CSPC Innovation Pharmaceutical's  first-in-class PD-1/IL-15 bispecific fusion protein, SYS6090 , received a fast track designation from the U.S. Food and Drug Administration, according to a Wednesday disclosure on the Shenzhen bourse.The Chinese pharmaceutical company's shares rose 4% during Thursday's afternoon trade.The drug is developed by the company's subsidiary, CSPC Giant Biopharmaceutical, as a treatment for patients with microsatellite-stable or mismatch repair-proficient metastatic colorectal cancer.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK0226","BK4588","BK4585","LABU","300765"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662058303","title":"IHH Healthcare's 2QFY2026 patmi up 29% y-o-y","url":"https://stock-news.laohu8.com/highlight/detail?id=2662058303","media":"The Edge Singapore ","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662058303?lang=en_us&edition=fundamental","pubTime":"2026-08-27 14:34","pubTimestamp":1787812483,"startTime":"0","endTime":"0","summary":"\"We remain confident on reaching double-digit ROE by 2028,\" says group CEO Dr Prem Kumar Nair","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"edge_highlight","url":"https://www.theedgesingapore.com/news/results/ihh-healthcares-2qfy2026-patmi-29-y-o-y?utm_source=Blog&utm_medium=RSS&utm_campaign=Tiger_Brokers_app_RSS","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.theedgesingapore.com/news/results/ihh-healthcares-2qfy2026-patmi-29-y-o-y?utm_source=Blog&utm_medium=RSS&utm_campaign=Tiger_Brokers_app_RSS","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"edge_highlight","symbols":["BK6092","LABU","BK4588","Q0F.SI","XLV","BK6511","BK4581","XBI","HCSG","BK4585","LU0128526141.USD","LU0029874061.USD","BK4137"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662577328","title":"Nicox Gets 2027 FDA Decision Date for Glaucoma Drug NCX 470","url":"https://stock-news.laohu8.com/highlight/detail?id=2662577328","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662577328?lang=en_us&edition=fundamental","pubTime":"2026-08-27 14:18","pubTimestamp":1787811533,"startTime":"0","endTime":"0","summary":"An update from Nicox SA ( ($FR:ALCOX) ) is now available. Nicox SA said the U.S. Food and Drug Administration has accepted the New Drug Application...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/nicox-gets-2027-fda-decision-date-for-glaucoma-drug-ncx-470?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/nicox-gets-2027-fda-decision-date-for-glaucoma-drug-ncx-470?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","LABU","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662745771","title":"Zymeworks (ZYME) Secures FDA Approval And $250 Million Milestone, Is The Stock Still Undervalued?","url":"https://stock-news.laohu8.com/highlight/detail?id=2662745771","media":"Simply Wall St.","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662745771?lang=en_us&edition=fundamental","pubTime":"2026-08-27 13:18","pubTimestamp":1787807892,"startTime":"0","endTime":"0","summary":"The latest move in Zymeworks (ZYME) stock comes after the U.S. FDA approved Ziihera, or zanidatamab hrii, for first line treatment of certain HER2 positive gastroesophageal cancers, triggering a US$250 million milestone from partner Jazz Pharmaceuticals.\nThe FDA decision appears to have reinforced investor confidence in Zymeworks, with the stock posting a 27.41% 1 month share price return and a 96.28% 1 year total shareholder return, while the 298.71% 3 year total shareholder return points to...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-zyme/zymeworks/news/zymeworks-zyme-secures-fda-approval-and-250-million-mileston","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-zyme/zymeworks/news/zymeworks-zyme-secures-fda-approval-and-250-million-mileston","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4585","BK4588","BK4139","ZYME","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662778957","title":"Promisia shareholders back acquisition and board fee increase at 2026 AGM","url":"https://stock-news.laohu8.com/highlight/detail?id=2662778957","media":"TIPRANKS","labels":["shareholding","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662778957?lang=en_us&edition=fundamental","pubTime":"2026-08-27 13:17","pubTimestamp":1787807834,"startTime":"0","endTime":"0","summary":"An update from Promisia Healthcare Limited ( ($NZ:PHL) ) is now available. Promisia Healthcare Limited has reported that all resolutions put to sha...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/promisia-shareholders-back-acquisition-and-board-fee-increase-at-2026-agm?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/promisia-shareholders-back-acquisition-and-board-fee-increase-at-2026-agm?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,merge","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","AGM","BK4588","XLV","BK4195","XBI","BK4229","BK4581","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662272723","title":"Alkane Resources Stock Tops Financially Strong Penny Stocks To Watch","url":"https://stock-news.laohu8.com/highlight/detail?id=2662272723","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662272723?lang=en_us&edition=fundamental","pubTime":"2026-08-27 10:32","pubTimestamp":1787797966,"startTime":"0","endTime":"0","summary":"Oil price declines are easing some inflation worries, which keeps central banks guessing and investors hunting for pockets of potential growth at a discount. That is where the Financially Fit Penny Stocks screener can help. It filters for lower priced stocks with stronger balance sheets than many early-stage peers. This article highlights three of the most interesting candidates and what to watch before you consider them.\nThe three stocks in this article are just a small sample, and the full...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/2053000-choice2-main-header/1585186554136","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/2053000-choice2-main-header/1585186554136"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/materials/asx-alk/alkane-resources-shares/news/alkane-resources-stock-tops-financially-strong-penny-stocks","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/materials/asx-alk/alkane-resources-shares/news/alkane-resources-stock-tops-financially-strong-penny-stocks","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["USG","XME","BGLD","DUST","IAUI","SGDM","PICK","UGL","YGLD","GLL","GLTR","GOLY","FGDL","PPI","GBUG","GDX","CEF","GDXW","GDXU","LABU","DBC","SHNY","RING","GLD","SGOL","DULL","AAAU","JNUG","BTGD","DGP","DZZ","JDST","GDXY","GLDM","SIG.AU","GOAU","XBI","BAR","ALK.AU","PHYS","GDXD","GDXJ","UYM","XLV","OUNZ","MSB.AU","IAU","IAUM","02840","BEGS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662263207","title":"Ramsay Health Care (RMSYF) Receives a Hold from Citi","url":"https://stock-news.laohu8.com/highlight/detail?id=2662263207","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662263207?lang=en_us&edition=fundamental","pubTime":"2026-08-27 08:35","pubTimestamp":1787790944,"startTime":"0","endTime":"0","summary":"In a report released today, Laura Sutcliffe from Citi maintained a Hold rating on Ramsay Health Care, with a price target of A$42.00. According to ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/ramsay-health-care-rmsyf-receives-a-hold-from-citi-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/ramsay-health-care-rmsyf-receives-a-hold-from-citi-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["XBI","BK4581","RMSYF","BK4185","BK4585","BK4588","LABU","XLV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662725898","title":"Sigma Healthcare-Chemist Warehouse Merger Delivers Strong First Full-Year Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2662725898","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662725898?lang=en_us&edition=fundamental","pubTime":"2026-08-27 07:59","pubTimestamp":1787788766,"startTime":"0","endTime":"0","summary":"Sigma Healthcare Ltd ( ($AU:SIG) ) has issued an announcement. Sigma Healthcare Limited operates as a major pharmacy wholesaler and retail healthca...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/sigma-healthcare-chemist-warehouse-merger-delivers-strong-first-full-year-results?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/sigma-healthcare-chemist-warehouse-merger-delivers-strong-first-full-year-results?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LABU","BK4585","XBI","LU0029874061.USD","BK4137","XLV","BK4588","LU0128526141.USD","BK4581","HCSG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662723595","title":"Ramsay Health Care Declares Interim Dividend of AUD 0.485 per Share","url":"https://stock-news.laohu8.com/highlight/detail?id=2662723595","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662723595?lang=en_us&edition=fundamental","pubTime":"2026-08-27 07:07","pubTimestamp":1787785640,"startTime":"0","endTime":"0","summary":"An update from Ramsay Health Care ( ($AU:RHC) ) is now available. Ramsay Health Care Limited has declared a fully paid ordinary dividend of AUD 0.4...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/ramsay-health-care-declares-interim-dividend-of-aud-0-485-per-share?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/ramsay-health-care-declares-interim-dividend-of-aud-0-485-per-share?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4581","CROC","VIG","XBI","BK4588","LABU","BK4585","XLV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662474427","title":"Health Care Down on Rotation Out of Biotech","url":"https://stock-news.laohu8.com/highlight/detail?id=2662474427","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662474427?lang=en_us&edition=fundamental","pubTime":"2026-08-27 05:43","pubTimestamp":1787780580,"startTime":"0","endTime":"0","summary":"Health-care companies fell as traders rotated out of high-risk biotech stocks.Revolution Medicines shares rose after the biotech firm received commercial approval from the Food and Drug Administration for a pancreatic cancer pill touted by former Nebraska Sen. Ben Sasse as a \"miracle drug\" during his treatment.A cyberattack at medical-device maker Boston Scientific triggered a global outage of key operational technology, leaving the company unable to fill orders.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["XBI","XLV","BK4588","BK4581","LABU","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662742406","title":"Vital Healthcare Property Trust Opens Director Nominations Ahead of November AGM","url":"https://stock-news.laohu8.com/highlight/detail?id=2662742406","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662742406?lang=en_us&edition=fundamental","pubTime":"2026-08-27 04:53","pubTimestamp":1787777612,"startTime":"0","endTime":"0","summary":"An announcement from Vital Healthcare Property ( ($NZ:VHP) ) is now available. Vital Healthcare Property Trust has set its Annual Meeting for 10 No...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/vital-healthcare-property-trust-opens-director-nominations-ahead-of-november-agm?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/vital-healthcare-property-trust-opens-director-nominations-ahead-of-november-agm?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","VHP.NZ","BK4195","BK4229","XBI","BK8073","BK4581","XLV","AGM","LABU","BK8059","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662874292","title":"Health Care Roundup: Market Talk","url":"https://stock-news.laohu8.com/highlight/detail?id=2662874292","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662874292?lang=en_us&edition=fundamental","pubTime":"2026-08-27 04:50","pubTimestamp":1787777400,"startTime":"0","endTime":"0","summary":"The latest Market Talks covering the Health Care sector. Published exclusively on Dow Jones Newswires at 4:20 ET, 12:20 ET and 16:50 ET.0343 ET - WuXi XDC Cayman retains its bull at Citi Research on s","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["XLV","XBI","BK4588","BK4585","BK4581","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662374230","title":"Revolution Medicines Earns Buy as RASONQUE FDA Approval and Strong Pricing Outlook Drive Price Target Increase to $315","url":"https://stock-news.laohu8.com/highlight/detail?id=2662374230","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662374230?lang=en_us&edition=fundamental","pubTime":"2026-08-27 04:25","pubTimestamp":1787775918,"startTime":"0","endTime":"0","summary":"LifeSci Capital analyst Charles Zhu maintained a Buy rating on Revolution Medicines today and set a price target of $315.00. Charles Zhu has given ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/revolution-medicines-earns-buy-as-rasonque-fda-approval-and-strong-pricing-outlook-drive-price-target-increase-to-315-ratings-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/revolution-medicines-earns-buy-as-rasonque-fda-approval-and-strong-pricing-outlook-drive-price-target-increase-to-315-ratings-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["RVMD","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1178759120","title":"FDA Grants Landmark Approval to Revolutionary Medicines' Pancreatic Cancer Therapy, Projected to Exceed $9 Billion in Sales by 2032","url":"https://stock-news.laohu8.com/highlight/detail?id=1178759120","media":"Deep News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1178759120?lang=en_us&edition=fundamental","pubTime":"2026-08-27 04:00","pubTimestamp":1787774418,"startTime":"0","endTime":"0","summary":"In a historic development for oncology, Revolution Medicines (RevMed) has secured US Food and Drug Administration (FDA) approval for its pancreatic cancer drug daraxonrasib, marking the first...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LABU","BK4588","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662741975","title":"FDA Approves Test to Identify Gastroesophageal Cancer Patients Eligible for Jazz Pharmaceuticals' Ziihera","url":"https://stock-news.laohu8.com/highlight/detail?id=2662741975","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662741975?lang=en_us&edition=fundamental","pubTime":"2026-08-27 03:52","pubTimestamp":1787773970,"startTime":"0","endTime":"0","summary":"The US Food and Drug Administration has approved usage of Roche's diagnostics tests to identify HER2-positive metastatic gastroesophageal adenocarcinoma patients who may be eligible for treatment with Jazz Pharmaceuticals'  Ziihera, Roche said Wednesday.Roche further said that two Ziihera-containing regimens are now FDA approved for the first-line treatment of adults with unresectable locally advanced or metastatic HER2-positive GEA.Shares of Jazz Pharmaceuticals were down 4.3% in Wednesday trading.Price: 250.04, Change: -10.19, Percent Change: -3.92","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["JAZZ","BK4585","LU0154245673.USD","BK4532","LU0154245756.USD","IE00BN0W2W23.USD","LU0889565916.HKD","IE00BN0W2T93.GBP","LU0109394709.USD","LU0320765992.SGD","IE00BN0W2V16.EUR","LU0823416689.USD","LABU","BK4588","BK4007","BK4533"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662744290","title":"3 AI Healthcare Stocks Retail Investors Are Watching In Australia","url":"https://stock-news.laohu8.com/highlight/detail?id=2662744290","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662744290?lang=en_us&edition=fundamental","pubTime":"2026-08-27 03:26","pubTimestamp":1787772401,"startTime":"0","endTime":"0","summary":"Global healthcare spending from governments remains in focus as China directs more public budget towards healthcare and social security. That kind of policy support can help AI healthcare companies find customers who are under pressure to cut costs and improve care quality at the same time. This article looks at 3 transformative AI healthcare stocks from our screener that aim to benefit from this long term shift.\nThe three stocks below are just a starting sample from this AI healthcare theme,...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/9551730-choice2-main-header/1585186975683","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/9551730-choice2-main-header/1585186975683"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/healthcare/asx-ime/imexhs-shares/news/3-ai-healthcare-stocks-retail-investors-are-watching-in-aust-1","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/healthcare/asx-ime/imexhs-shares/news/3-ai-healthcare-stocks-retail-investors-are-watching-in-aust-1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["LU0128526141.USD","OZF.AU","GEAR.AU","NOBL","BBOZ.AU","BK4585","BK7094","HCSG","CHAT","IMLC.AU","LU0029874061.USD","IXJ","AGIX","STW.AU","E200.AU","IIGF.AU","LABU","QFN.AU","VAP.AU","VAS.AU","ZYAU.AU","AYA.AU","XAO.AU","BK4581","BEAR.AU","ARTY","XKO.AU","XBI","CGCV","AIPO","IOZ.AU","BK4550","QTOC","QRE.AU","XJO.AU","BK4137","IME.AU","VTHR","IISV.AU","OZR.AU","ISBC","GIVE.AU","TCAF","EIGA.AU","SHG.AU","VHT","DACE.AU","XLV","SLF.AU","VGT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662497867","title":"Sector Update: Healthcare","url":"https://stock-news.laohu8.com/highlight/detail?id=2662497867","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662497867?lang=en_us&edition=fundamental","pubTime":"2026-08-27 03:07","pubTimestamp":1787771265,"startTime":"0","endTime":"0","summary":"Healthcare stocks declined late Wednesday afternoon, with the NYSE Healthcare Index falling 1% and the State Street Health Care Select Sector SPDR ETF  down 0.9%.The iShares Biotechnology ETF  decreased 0.5%.In corporate news, Eli Lilly  said Wednesday that a real-world study showed sustained use of its weight-management drug Zepbound was associated with lower healthcare costs among adults older than 55 with overweight or obesity, compared with similar untreated adults. Lilly shares were down 3.3%.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU0096364046.USD","SG9999017495.SGD","LU2361044949.HKD","LU2357305700.SGD","LU2468319806.SGD","LU1551013342.USD","LU2461242641.AUD","LU1988902786.USD","IE00B7KXQ091.USD","LU1069344957.HKD","LU0203202063.USD","LU2491049909.HKD","PPH","BK4581","LU2087625088.SGD","BK4533","BK4599","LU2023251221.USD","LU2237438978.USD","LU1548497426.USD","TMED","IE00BFSS7M15.SGD","LLYZ","SG9999015978.USD","LU0823434583.USD","LU2089283258.USD","ILDR","LU1127390331.HKD","LU2237443465.HKD","LU1868836914.USD","LU1551013425.SGD","LU2237443622.USD","LU2361045086.USD","LU0266013472.USD","LU1917777945.USD","LU2552382058.USD","LU2491050154.USD","GB00BDT5M118.USD","IXJ","LU0943347566.SGD","IE00BKDWB100.SGD","CURE","LU0238689110.USD","VHT","LU0006306889.USD","LU1868836757.USD","LU0106261372.USD","SG9999013999.USD","LU0210536198.USD","LU1868836591.USD","LU2237443549.SGD","LU2360106947.USD","LU2552382215.SGD","ELIL","LU1720051017.SGD","IE00BFSS8Q28.SGD","BK4007","LU2028103732.USD","LU0094547139.USD","LU2211815571.USD","LU1145028129.USD","LU2491050071.SGD","LU1280957306.USD","SG9999018865.SGD","LU0820562030.AUD","THNR","IE00B1XK9C88.USD","LU1366192091.USD","LU0820561818.USD","SGXZ51526630.SGD","LU2462591350.SGD","LU0198837287.USD","LU2750360997.AUD","LU0122379950.USD","LU2108987350.USD","LU0354030511.USD","IE0004445015.USD","BK4585","LU0174119429.USD","LU2168564495.EUR","IE0004445239.USD","LU0345770308.USD","LU0823434740.USD","LU2462157665.USD","LU0158827948.USD","LU1712237335.SGD","LU0882574139.USD","IE00BJJMRZ35.SGD","IE00BFTCPJ56.SGD","LU0820561909.HKD","FTXH","LU1232071149.USD","RXL","LU0786609619.USD","BK4516","LU0323591593.USD","LU0203201768.USD","SGXZ99366536.SGD","LU0316494557.USD","LU2746668461.USD","LU2106854487.HKD","IBB","IE00B2B36J28.USD","LU0823416689.USD","LU2089284900.SGD","LU2471134879.HKD","JDOC","TRUH","CANC","IE00BJLML261.HKD","LU2168564222.USD","IE00BWXC8680.SGD","LU2063271972.USD","LU2264538146.SGD","LU0456855351.SGD","LU2168564149.EUR","LU1691799644.USD","LU2237443895.HKD","LU1989771016.USD","LU0320765992.SGD","LU2750360641.GBP","SG9999014880.SGD","LU0689472784.USD","LU2168564065.EUR","LLII","IYH","LU1868837136.USD","LU0432979614.USD","SG9999014898.SGD","LU2456880835.USD","IE0001KFT4U8.USD","IE00B1BXHZ80.USD","IE0005OL40V9.USD","FHLC","LU0256863902.USD","LU0289739699.SGD","LU0061475181.USD","LU2168563687.JPY","GDOC","IE0009355771.USD","LU2602419157.SGD","LU2471134952.CNY","LLYX","LU1267930730.SGD","AGNG","LU0385154629.USD","LU0466842654.USD","LU0889565916.HKD","IE00B4R5TH58.HKD","LU1061106388.HKD","LU2265009873.SGD","LU2471134796.USD","MEDI","LU0787776722.HKD","LU1979441026.SGD","IE00BJJMRY28.SGD","LU2089984988.USD","LU0471298694.HKD","LU2023250504.SGD","LU1814569148.SGD","LU1291159041.SGD","LU2271345857.HKD","SG9999015952.SGD","LU2023250330.USD","LU2746668974.SGD","LU2324357040.USD","LU0672654240.SGD","LU1868837300.USD","LU0640476718.USD","LU1983299246.USD","LU1629891620.HKD","SG9999014914.USD","XLV","LU0320765059.SGD","SG9999015986.USD","LU2471134523.USD","SGXZ57979304.SGD","IE00BJT1NW94.SGD","OZEM","LU0964807845.USD","LU0114720955.EUR","LU0256863811.USD","LU0353189680.USD","IE00BN29S564.USD","SGXZ81514606.USD","LU1323610961.USD","LU0354030438.USD","IE00BK4W5L77.USD","LU2236285917.USD","IE00BJJMRX11.SGD","IE00BKPKM429.USD","LU0225283273.USD","LU0345770993.USD","LU0683600562.USD","LU1064131342.USD","LABU","LU1720051108.HKD","LU1804176565.USD","LU2213496289.HKD","SG9999001176.USD","SG9999015945.SGD","LU2896262040.SGD","IHE","LU0353189763.USD","LU2417539215.USD","LU0097036916.USD","LU1093756168.USD","IE0002141913.USD","LLY","LU1974910355.USD","MEDX","LU0109394709.USD","LU2756315318.SGD","SG9999018857.SGD","LU0133085943.USD","BK4534","LU0708995401.HKD","MHIP","LU0109391861.USD","LU0158827781.USD","ELIS","LU0079474960.USD","LU1057294990.SGD","LU1093756325.SGD","PJP","SG9999014906.USD","SGXZ31699556.SGD","WDNA","LU2552382132.HKD","LU2111349929.HKD","LU0471298777.SGD","LU1623119135.USD","SG9999001176.SGD","LU2237443382.USD","HRTS","LU1023059063.AUD","BK4588","LU0058720904.USD","XBI","LU0882574055.USD","IE00B775H168.HKD","IE00BK4W5M84.HKD","LU0417517546.SGD","LU1035775433.USD","LU2361044865.SGD","LU0234572021.USD","IE00B4JS1V06.HKD","LU2237443978.SGD","LU2112291526.USD","LU2756315664.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662874134","title":"Roche receives FDA approval for companion diagnostic tests for Ziihera","url":"https://stock-news.laohu8.com/highlight/detail?id=2662874134","media":"TIPRANKS","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662874134?lang=en_us&edition=fundamental","pubTime":"2026-08-27 03:00","pubTimestamp":1787770816,"startTime":"0","endTime":"0","summary":"Roche (RHHBY) announced that it has received FDA approval for expanded use of its PATHWAY HER2 and VENTANA HER2 Dual ISH DNA Probe Cocktail tests. ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/roche-receives-fda-approval-for-companion-diagnostic-tests-for-ziihera-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/roche-receives-fda-approval-for-companion-diagnostic-tests-for-ziihera-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["NVIB","BBP","XLVX","BK4585","RSPH","GNMX","MRNY","BK4007","IEIH","FRTY","LABU","PSCH","MEDI","SYNB","BK4588","HRTS","GDOC","03165","MRNX","TECB","BMED","IYH","CANC","IBB","IDNA","TBXU","LFSC","PINK","RHHBY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662749608","title":"Analysts’ Top Healthcare Picks: CVS Health (CVS), TuHURA Biosciences (HURA)","url":"https://stock-news.laohu8.com/highlight/detail?id=2662749608","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662749608?lang=en_us&edition=fundamental","pubTime":"2026-08-27 02:20","pubTimestamp":1787768419,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on CVS Health (CVS) and TuHURA Biosciences (HURA) with ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-top-healthcare-picks-cvs-health-cvs-tuhura-biosciences-hura-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-top-healthcare-picks-cvs-health-cvs-tuhura-biosciences-hura-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IE00B7SZLL34.SGD","LU1571399168.USD","LU1923622614.USD","LU2125909247.SGD","IE00B19Z3B42.SGD","IE00BSNM7G36.USD","HURA","IE00BKVL7J92.USD","LABU","BK4504","LU1059921491.USD","XLV","LU0061475181.USD","LU0029874061.USD","RTH","IE0002270589.USD","LU0162691827.USD","HCSG","LU0006061336.USD","LU2357627491.SGD","LU0128526141.USD","LU0211331839.USD","LU0070302665.USD","LU0320765489.SGD","LU1236620750.USD","LU2125909593.SGD","BK4581","LU1236620834.HKD","IE00B19Z3581.USD","LU1983299246.USD","BK4550","LU2433249047.HKD","BK4196","IE00BZ1G4Q59.USD","LU0208291251.USD","LU0432979614.USD","LU1699723380.USD","BK4585","BK4588","IHF","XBI","BK4139","BK4137","CVS","LU0072461881.USD","LU0859254822.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662493367","title":"Botanix Pharm: Strong Sofdra Adoption and Margin Upside Support Buy Rating with Unchanged $1 Price Target","url":"https://stock-news.laohu8.com/highlight/detail?id=2662493367","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662493367?lang=en_us&edition=fundamental","pubTime":"2026-08-27 02:05","pubTimestamp":1787767521,"startTime":"0","endTime":"0","summary":"Botanix Pharmaceuticals Limited, the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Joseph Pantginis from H.C. Wa...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/botanix-pharm-strong-sofdra-adoption-and-margin-upside-support-buy-rating-with-unchanged-1-price-target-ratings-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/botanix-pharm-strong-sofdra-adoption-and-margin-upside-support-buy-rating-with-unchanged-1-price-target-ratings-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","XLV","BK4581","LABU","XBI","BK4585"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":21,"pageCount":8,"totalSize":410,"code":"91000000","status":"200"}]}}